Premium
In Vitro Toxicity of Asparagus Saponins in Distinct Multidrug‐Resistant Colon Cancer Cells
Author(s) -
JaramilloCarmona Sara,
GuillénBejarano Rafael,
JiménezAraujo Ana,
RodríguezArcos Rocío,
López Sergio
Publication year - 2018
Publication title -
chemistry and biodiversity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 70
eISSN - 1612-1880
pISSN - 1612-1872
DOI - 10.1002/cbdv.201800282
Subject(s) - asparagus , chemistry , colorectal cancer , cytotoxic t cell , in vitro , nutraceutical , pharmacology , toxicity , cancer , traditional medicine , biochemistry , botany , biology , medicine , organic chemistry , genetics
Abstract Colorectal cancer is the third most common cancer in the world. Many efforts have focused on finding natural molecules with potential chemo‐preventive activity due to their low toxicity compared to synthetic drugs. However, comprehensive information on the bioactive fractions and components is still missing. In this study, we developed a method for the quantitative separation and isolation of saponins from asparagus genotypes consisting of an adsorption chromatography and subsequent liquid chromatographic separation on a reversed‐phase column. The saponins isolated were tested for their cytotoxic activity against human colon cancer cell lines, which could develop cross‐resistance to a wide variety of chemotherapeutic drugs. Our results showed that Huétor‐Tájar asparagus saponins (HTSAP), mainly protodioscin and HTSAP‐10 have higher cytotoxic activity than HTSAP‐1, HTSAP‐6, and HTSAP‐8. This study links the potential anticancer effect of asparagus to specific saponins and unveils the triguero Huétor‐Tájar asparagus as a nutraceutical particularly in colon cancer therapies.